This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Bactoclear Holdings Pte. Ltd, Gangagen, Inc.. Active years: 2017-2024.
Location History:
- Bangalaore, IN (2017)
- Bengaluru, IN (2018 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: Chemira B Appaiah: Innovator in Therapeutic Bacteriocins
Introduction
Chemira B Appaiah is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of microbiology, particularly in the development of therapeutic compositions aimed at combating infections. With a total of 4 patents to her name, her work is paving the way for innovative solutions in healthcare.
Latest Patents
Among her latest patents, Chemira has developed therapeutic bacteriocins, which provide methods and compositions to reduce the growth of microbial colonies, including infections. This invention includes therapeutic compositions, methods for the treatment of infections, and methods for identifying additional such compositions. Another notable patent is for chimeric lysm polypeptides, which outlines antibacterial compositions and methods for making and using these compositions.
Career Highlights
Throughout her career, Chemira has worked with several companies, including Bactoclear Holdings Pte. Ltd and Gangagen, Inc. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in the field.
Collaborations
Chemira has collaborated with notable individuals in her field, including Vivek Daniel Paul and R Sanjeev Saravanan. These partnerships have further enhanced her research and development efforts.
Conclusion
Chemira B Appaiah is a trailblazer in the realm of therapeutic innovations, with her patents reflecting her commitment to improving healthcare solutions. Her work continues to inspire future advancements in microbiology and infection treatment.